Issues

Volume 1 - Issue 1, November-December 2007

Thu, 1 Nov 2007

Cardiology_V1_I1-1.jpg

In this Issue

  • Table of contents
  • Editorial Board
  • Download pdf (print optimised)
  • Download pdf (screen optimised)

Editorial

  • Editorial

    Dear readers, Better management practices can have a profoundly positive impact on the efficiency of any medical department. An exchange of management information and experiences will inevitably allow for a more efficient and patient-orientated provision of services, as well as a more informed medical team. While at a general hospital level, management awareness is more clearly evident, cardiologists...

    READ MORE

Exhibitors @ RSNA 2010

  • Cordis Appoints New Vice-President of Microelectronic Technologies

    Cordis Corporation has announced the appointment of Joseph M. Smith, M.D., Ph.D. to Vice President, Microelectronic Technologies. Dr. Smith will lead the company’s efforts to develop implantable microelectronic technologies in the management of cardiovascular disease. Dr. Smith brings more than 25 years experience in cardiac rhythm management (CRM) to Cordis Corporation. Most recently, he served as Senior...

    READ MORE
  • Cardio Dynamics Gains Support for Vermed Sale

    CardioDynamics International has reported that it is progressing with its shareholders’ approval for the sale of its Vermed business unit. The company reached an agreement to sell the Vermed unit to the subsidiary's management team for a cash purchase price of $8 million in late June this year. Vermed is a supplier of disposable electrodes and related supplies utilised in electrocardiograph (ECG) and oth...

    READ MORE
  • ISHR/Servier Research Fellowship Winner Announced

    The ISHR-ES SERVIER Research Fellowship has been presented to Dr Marta Roccio, a postdoctoral research fellow at the Department of Cardiology and Laboratory of Experimental Cardiology University of Utrecht, Utrecht, The Netherlands. Dr Roccio's project is titled: "Molecular mechanisms of cardiac progenitor cells differentiation". This 20,000 Euro grant is offered for the sixth time by SERVIER in partnership...

    READ MORE
  • First Patient Enrolled in Clinical Trial to Study Drug Sluting Stent Treatment in Women

    Abbott has announced that the first patient was enrolled in its Xience V Spirit Women clinical trial, the world’s first clinical trial designed to study the safety and effectiveness of drug eluting stent treatment in women. Liliana Grinfeld, M.D., of the Hospital Italiano in Buenos Aires, Argentina, performed the first procedure. The goal of the trial is to increase understanding of how heart disease affe...

    READ MORE
  • Medtronic Announces European Introduction of Cardiac Monitor

    Medtronic has announced the European introduction of Reveal® XT, the first Insertable Cardiac Monitor that offers longterm and continuous monitoring of Atrial Fibrillation (AF). All other current monitoring tools are either for a limited period or on an intermittent basis. Longterm, continuous monitoring means that a clinician no longer needs to rely only on incomplete data to evaluate how AF may be progre...

    READ MORE
  • Millar Launches World's Smallest Sensor Tip Pressure-Volume Catheter

    Millar Instruments, developer and manufacturer of Mikro-Tip® pressure transducer catheters and pressure-volume (P-V) systems, today announced the expansion of its French catheter line with the introduction of the PVR-1045 pressure-volume catheter. With a catheter tip size of 1F (1/3 mm), the PVR-1045 is the smallest and least invasive sensor tip pressure-volume catheter available on the market. The smalle...

    READ MORE
  • Boston Scientific to Explore Sale of Cardiac & Vascular Surgery Businesses

    Boston Scientific announced it intends to explore the sale of its cardiac surgery and vascular surgery businesses as part of its plan to review its portfolio of assets and divest those considered nonstrategic, and to strengthen its operating and financial performance. Paul LaViolette, chief operating officer of Boston Scientific noted that if finalised, the sale will support the company’s efforts to focus...

    READ MORE
  • Sanofi-Aventis Announces Approval of Labelling Update of Acomplia® in Europe

    Sanofi-Aventis announced that the Committee for Medicinal Products for Human Use (CHMP), after re-evaluation, confirms the positive benefit-risk profile of rimonabant in the indicated patient population and has issued a positive opinion on the labelling update. Acomplia® labelling has been updated based on data reflecting one year of post-marketing experience mainly from Germany, France and the UK, as well...

    READ MORE
  • Schering-Plough Corporation Prices Public 0ffering

    Schering-Plough Corporation has announced that it priced its registered public offering of 50,000,000 common shares at $27.50 per share. The underwriters have an option to purchase up to an additional 7,500,000 common shares from Schering- Plough. Schering-Plough also announced that it has concurrently priced its registered public offering of 10,000,000 shares of its 6.00% mandatory convertible preferred st...

    READ MORE
  • Cardiatis Completes Stent Trial Recruitment

    Cardiatis of Brussels, Belgium, has completed recruitment of patients into its first-in-man European clinical trial of its FluidSmart 3D multilayer braided stent for repairing aneurysms. Patient recruitment, which began in December last year, culminates four years of extensive concept testing that demonstrated the ability of the 3D multilayer stent to repair aneurysms endovascularly without the need for coi...

    READ MORE

Cover Story: Improving Clinical & Economic Effectiveness

Features